X4 PHARMACEUTICALS, INC
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $50.1M | $122.9M | $78.7M |
| FY2021 | $52.8M | $117.2M | $81.8M |
| FY2022 | $81.5M | $155.6M | $121.7M |
| FY2023 | $96.2M | $147.3M | $99.2M |
| FY2024 | $124.3M | $146.4M | $55.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $50.1M | $122.9M | $78.7M |
| FY2021 | $52.8M | $117.2M | $81.8M |
| FY2022 | $81.5M | $155.6M | $121.7M |
| FY2023 | $96.2M | $147.3M | $99.2M |
| FY2024 | $124.3M | $146.4M | $55.7M |